SEXTA Proffered Paper session - Breast cancer, early stage Channel 5 Friday, 17 September, 08:30—09:50119O Event-free survival (EFS), overall survival (OS), and safety of adding veliparib (V) plus carboplatin (Cb) or carboplatin alone to neoadjuvant [...]
Sobre BIOThis author has not yet filled in any Detalhes.
So far BIO has created 58 blog entries.
SEXTA Session : Proffered Paper session - Gynaecological cancers Channel 3 Friday, 17 September, 08:30—09:50 Presentation LBA33 : Maintenance olaparib rechallenge in patients (pts) with ovarian carcinoma (OC) previously treated with a PARP inhibitor (PARPi): [...]
Sexta-feira, 17/09/2021 Bexiga 8:30-8:40: LBA27 - Erdafitinib (ERDA) or ERDA plus cetrelimab (CET) for patients with metastatic or locally advanced urothelial carcinoma (mUC) and Fibroblast Growth Factor Receptor alterations (FGFRa): First phase (Ph) II results [...]
Melhores estudos em Tumores Gastrointestinais da ESMO 2021 Dr. André Sasse – Oncologista e Dr. Fernando Sabino – OncologistaBIO2021-09-14T13:09:44-03:00
TUMORES GASTROINTESTINAIS – COLON E RETO Sessão Presidencial 2 (domingo, 19/set) LBA6 - KRYSTAL-1: Adagrasib (MRTX849) as Monotherapy or Combined with Cetuximab (Cetux) in Patients (Pts) With Colorectal Cancer (CRC) Harboring a KRASG12C Mutation Sábado, [...]
Melhores estudos em Câncer de Pulmão da ESMO 2021 Dr. Adriano Silva- Oncologista e Dr. Igor Morbeck – OncologistaBIO2021-09-13T18:08:03-03:00
Virtual Debate VP2_2021 - Effectiveness of PD-(L)1 inhibitors alone or in combination with platinum-doublet chemotherapy in first-line (1L) non-squamous non-small cell lung cancer (Nsq-NSCLC) with high PD-L1 expression using real-world data Presidential 3 LBA9 - [...]
16.09.2021 When and how should age influence treatment Session Track Head and neck cancer, excl. thyroid 08:30 - 09:20 Type: Educational session Title: The emerging role of immunotherapy in the curative setting 08:35 [...]